Nomura Asset Management International’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Nomura Asset Management International's ADPT Position: Q2 2026 in Review
Nomura Asset Management International increased its Adaptive Biotechnologies (ADPT) stake by 0.43% in Q2 2026, buying an estimated $123K and bringing the position to 1,889,188 shares worth $40.5M. The position accounts for 0.06% of the portfolio, ranked #414.
Nomura Asset Management International first reported a position in ADPT in Q4 2025 and has held it in 3 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.
- Nomura Asset Management International held 1,889,188 shares of Adaptive Biotechnologies worth $40.5M as of Q2 2026.
- Nomura Asset Management International bought 8,005 Adaptive Biotechnologies shares in Q2 2026, an estimated $123K.
- Adaptive Biotechnologies made up 0.06% of Nomura Asset Management International's portfolio in Q2 2026, its #414 holding.
- Nomura Asset Management International first reported a position in Adaptive Biotechnologies in Q4 2025 and has held it in 3 quarters since.
- 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.
Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.